rs11906160

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_020884.7(MYH7B):​c.-54G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.115 in 1,613,514 control chromosomes in the GnomAD database, including 12,161 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.15 ( 2157 hom., cov: 32)
Exomes 𝑓: 0.11 ( 10004 hom. )

Consequence

MYH7B
NM_020884.7 5_prime_UTR

Scores

15

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -3.94

Publications

51 publications found
Variant links:
Genes affected
MYH7B (HGNC:15906): (myosin heavy chain 7B) The myosin II molecule is a multi-subunit complex consisting of two heavy chains and four light chains. This gene encodes a heavy chain of myosin II, which is a member of the motor-domain superfamily. The heavy chain includes a globular motor domain, which catalyzes ATP hydrolysis and interacts with actin, and a tail domain in which heptad repeat sequences promote dimerization by interacting to form a rod-like alpha-helical coiled coil. This heavy chain subunit is a slow-twitch myosin. Alternatively spliced transcript variants have been found, but the full-length nature of these variants is not determined. [provided by RefSeq, Mar 2010]
MYH7B Gene-Disease associations (from GenCC):
  • left ventricular noncompaction
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.004963815).
BP6
Variant 20-34977952-G-A is Benign according to our data. Variant chr20-34977952-G-A is described in ClinVar as Benign. ClinVar VariationId is 1570582.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.26 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MYH7BNM_020884.7 linkc.-54G>A 5_prime_UTR_variant Exon 5 of 45 ENST00000262873.13 NP_065935.4 A7E2Y1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MYH7BENST00000262873.13 linkc.-54G>A 5_prime_UTR_variant Exon 5 of 45 1 NM_020884.7 ENSP00000262873.8 A0A6E1W127
MYH7BENST00000470929.5 linkn.33G>A non_coding_transcript_exon_variant Exon 2 of 6 2
MYH7BENST00000673749.1 linkn.481G>A non_coding_transcript_exon_variant Exon 5 of 9

Frequencies

GnomAD3 genomes
AF:
0.154
AC:
23361
AN:
151950
Hom.:
2150
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.264
Gnomad AMI
AF:
0.116
Gnomad AMR
AF:
0.101
Gnomad ASJ
AF:
0.110
Gnomad EAS
AF:
0.0832
Gnomad SAS
AF:
0.138
Gnomad FIN
AF:
0.146
Gnomad MID
AF:
0.0981
Gnomad NFE
AF:
0.110
Gnomad OTH
AF:
0.127
GnomAD2 exomes
AF:
0.123
AC:
30555
AN:
249176
AF XY:
0.125
show subpopulations
Gnomad AFR exome
AF:
0.267
Gnomad AMR exome
AF:
0.0648
Gnomad ASJ exome
AF:
0.105
Gnomad EAS exome
AF:
0.0976
Gnomad FIN exome
AF:
0.143
Gnomad NFE exome
AF:
0.115
Gnomad OTH exome
AF:
0.121
GnomAD4 exome
AF:
0.111
AC:
162856
AN:
1461444
Hom.:
10004
Cov.:
33
AF XY:
0.113
AC XY:
81866
AN XY:
727032
show subpopulations
African (AFR)
AF:
0.267
AC:
8931
AN:
33478
American (AMR)
AF:
0.0709
AC:
3171
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.104
AC:
2721
AN:
26134
East Asian (EAS)
AF:
0.0718
AC:
2849
AN:
39700
South Asian (SAS)
AF:
0.154
AC:
13299
AN:
86254
European-Finnish (FIN)
AF:
0.141
AC:
7509
AN:
53074
Middle Eastern (MID)
AF:
0.131
AC:
753
AN:
5756
European-Non Finnish (NFE)
AF:
0.105
AC:
116466
AN:
1111938
Other (OTH)
AF:
0.119
AC:
7157
AN:
60386
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
8424
16848
25271
33695
42119
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
4268
8536
12804
17072
21340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.154
AC:
23394
AN:
152070
Hom.:
2157
Cov.:
32
AF XY:
0.156
AC XY:
11558
AN XY:
74318
show subpopulations
African (AFR)
AF:
0.264
AC:
10950
AN:
41466
American (AMR)
AF:
0.100
AC:
1532
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.110
AC:
380
AN:
3468
East Asian (EAS)
AF:
0.0826
AC:
427
AN:
5168
South Asian (SAS)
AF:
0.138
AC:
666
AN:
4820
European-Finnish (FIN)
AF:
0.146
AC:
1549
AN:
10584
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.110
AC:
7485
AN:
67960
Other (OTH)
AF:
0.129
AC:
273
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
975
1950
2925
3900
4875
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
250
500
750
1000
1250
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.122
Hom.:
4695
Bravo
AF:
0.154
TwinsUK
AF:
0.0960
AC:
356
ALSPAC
AF:
0.105
AC:
405
ESP6500AA
AF:
0.240
AC:
1039
ESP6500EA
AF:
0.111
AC:
950
ExAC
AF:
0.129
AC:
15608
Asia WGS
AF:
0.129
AC:
446
AN:
3478
EpiCase
AF:
0.112
EpiControl
AF:
0.112

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MYH7B-related disorder Benign:1
Dec 20, 2019
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.12
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
0.44
DANN
Benign
0.64
Eigen
Benign
-1.6
Eigen_PC
Benign
-1.8
FATHMM_MKL
Benign
0.0099
N
LIST_S2
Benign
0.31
T;T
MetaRNN
Benign
0.0050
T;T
MetaSVM
Benign
-1.1
T
PhyloP100
-3.9
PrimateAI
Benign
0.28
T
PROVEAN
Benign
-0.010
N;.
REVEL
Benign
0.13
Sift
Benign
0.55
T;.
Vest4
0.0060
MPC
0.45
ClinPred
0.013
T
GERP RS
-9.1
PromoterAI
-0.025
Neutral
Varity_R
0.014
gMVP
0.47
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11906160; hg19: chr20-33565755; COSMIC: COSV53420686; COSMIC: COSV53420686; API